These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22350548)

  • 21. [New methods of the treatment of retinal dystrophies].
    Langrová H; Kratochvílová V
    Cesk Slov Oftalmol; 2013 Aug; 69(3):106-9. PubMed ID: 24437957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral Subretinal Voretigene Neparvovec-rzyl (Luxturna) Gene Therapy.
    Weng CY
    Ophthalmol Retina; 2019 May; 3(5):450. PubMed ID: 31044739
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on Viral Gene Therapy Clinical Trials for Retinal Diseases.
    Cheng SY; Punzo C
    Hum Gene Ther; 2022 Sep; 33(17-18):865-878. PubMed ID: 36074935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
    Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
    Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Navigating the current landscape of clinical genetic testing for inherited retinal dystrophies.
    Lee K; Garg S
    Genet Med; 2015 Apr; 17(4):245-52. PubMed ID: 25790163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited retinal diseases: Therapeutics, clinical trials and end points-A review.
    Georgiou M; Fujinami K; Michaelides M
    Clin Exp Ophthalmol; 2021 Apr; 49(3):270-288. PubMed ID: 33686777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.
    Talib M; Boon CJF
    Asia Pac J Ophthalmol (Phila); 2020; 9(3):159-179. PubMed ID: 32511120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in
    Boon N; Alves CH; Mulder AA; Andriessen CA; Buck TM; Quinn PMJ; Vos RM; Koster AJ; Jost CR; Wijnholds J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in research on pathogenic genes and gene therapy for inherited retinal diseases].
    Zhu L; Cao C; Sun J; Gao T; Liang X; Nie Z; Ji Y; Jiang P; Guan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):118-123. PubMed ID: 28186610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic ocular diseases].
    Hamel CP
    Rev Prat; 2015 Apr; 65(4):467-70. PubMed ID: 26058181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies.
    Gerard X; Garanto A; Rozet JM; Collin RW
    Adv Exp Med Biol; 2016; 854():517-24. PubMed ID: 26427454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.
    Kumaran N; Moore AT; Weleber RG; Michaelides M
    Br J Ophthalmol; 2017 Sep; 101(9):1147-1154. PubMed ID: 28689169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.
    Garanto A; Collin RWJ
    Methods Mol Biol; 2018; 1715():61-78. PubMed ID: 29188506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
    Rakoczy EP; Narfström K
    Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical Aspects in Gene Therapy for Inherited Retinal Diseases.
    Fischer MD; Bartz-Schmidt KU; Dimopoulos S; Herrmann P; Gerhardt M; Holz FG; Priglinger S
    Klin Monbl Augenheilkd; 2021 Mar; 238(3):267-271. PubMed ID: 33618387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons Learned from the Development of the First FDA-Approved Gene Therapy Drug, Voretigene Neparvovec-rzyl.
    Bennett J; Maguire AM
    Cold Spring Harb Perspect Med; 2023 May; 13(5):. PubMed ID: 36167727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implementation of a new gene therapy in ophthalmology: Regulatory and organizational issues].
    Daruich A; Boinet R; Falcou C; Cotteret C; Magassa A; Schlatter J; Escalup R; Cisternino S; Valleix S; Robert MP; Bremond-Gignac D
    J Fr Ophtalmol; 2021 May; 44(5):730-737. PubMed ID: 33838946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the management of Inherited Retinal Dystrophies by targeted sequencing of a population-specific gene panel.
    Bravo-Gil N; Méndez-Vidal C; Romero-Pérez L; González-del Pozo M; Rodríguez-de la Rúa E; Dopazo J; Borrego S; Antiñolo G
    Sci Rep; 2016 Apr; 6():23910. PubMed ID: 27032803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First Million-Dollar Syringe Could Be a Sight for Sore Eyes.
    Morrow T
    Manag Care; 2015 Sep; 24(9):38-9. PubMed ID: 26521338
    [No Abstract]   [Full Text] [Related]  

  • 40. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
    Kondkar AA; Abu-Amero KK
    Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.